Biosig Technologies Inc
NASDAQ:BSGM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biosig Technologies Inc
NASDAQ:BSGM
|
US |
Balance Sheet
Balance Sheet Decomposition
Biosig Technologies Inc
Biosig Technologies Inc
Balance Sheet
Biosig Technologies Inc
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
4
|
12
|
28
|
12
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
4
|
12
|
28
|
12
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
5
|
13
|
29
|
14
|
1
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+14%
|
0
+8%
|
0
+0%
|
1
+192%
|
1
+20%
|
2
+37%
|
5
+194%
|
14
+185%
|
30
+114%
|
16
-49%
|
4
-74%
|
2
-56%
|
1
-53%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
2
|
3
|
4
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
2
|
1
|
2
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
3
|
1
|
2
|
3
|
4
|
1
|
2
|
5
|
3
|
3
|
5
|
2
|
|
| Long-Term Debt |
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
3
+203%
|
3
-11%
|
1
-59%
|
2
+102%
|
3
+20%
|
4
+34%
|
1
-70%
|
3
+138%
|
6
+107%
|
3
-46%
|
4
+16%
|
5
+28%
|
2
-52%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
2
|
3
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
4
|
14
|
23
|
32
|
44
|
57
|
71
|
105
|
157
|
189
|
216
|
245
|
255
|
|
| Additional Paid In Capital |
1
|
1
|
9
|
19
|
29
|
41
|
53
|
74
|
116
|
181
|
201
|
216
|
242
|
254
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
3
-268%
|
3
+13%
|
1
+67%
|
1
-65%
|
2
-19%
|
2
-32%
|
4
N/A
|
11
+199%
|
24
+115%
|
12
-50%
|
0
-97%
|
3
N/A
|
1
+51%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+14%
|
0
+8%
|
0
+0%
|
1
+192%
|
1
+20%
|
2
+37%
|
5
+194%
|
14
+185%
|
30
+114%
|
16
-49%
|
4
-74%
|
2
-56%
|
1
-53%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
5
|
9
|
17
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|